LIFR and breast carcinoma: Also recently, leukemia inhibitory factor receptor (LIFR), a gene present in our prognostic invasion signature, was found to exert anti-metastatic effects through activation of the Hippo pathway and functional inactivation of the transcriptional co-activator YAP. A significant association between loss of LIFR and poor prognosis in breast cancer has been discovered as well [33].